Funding for this research was provided by:
National Institutes of Health (U44: 50781)
Received: 24 April 2019
Accepted: 24 June 2019
First Online: 23 July 2019
Ethics approval and consent to participate
: Experimental procedures and the consent form were approved by the Institutional Review Board (IRB) of the Feinstein Institute for Medical Research at Northwell Health (IRB #15110) and follows NIH guidelines for ethical human subject research.
: Informed consent was obtained for all participants in this study.
: Dr. Zaghloul Ahmed is the scientific founder of Pathmaker, LLC., which manufacturers the device that delivers the double stimulation. All other authors declare that they have no competing interests.